FDA Seeks Input on Clinical Investigation Requirements

Clinical Trials Advisor
A A
The FDA is requesting industry feedback on the burdens related to its regulation of clinical safety and efficacy trials of unapproved new drugs and biologics.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00